![Photo](/media/story/21735/thumbnail-01-johns-hopkins-medicine-macular-degeneration.jpg)
News • Macular Degeneration
Implanted drug ‘reservoir’ reduces injections
In a clinical trial of 220 people with “wet” age-related macular degeneration, Johns Hopkins Medicine researchers, collaborators from many sites across the country, and Genentech in South San Francisco have added to evidence that using a new implant technology that continuously delivers medication into the eyes is safe and effective in helping maintain vision and reduces the need for…